Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Tax Payment
Common Stock
2024-03-09$4.88/sh−5,895$28,768→ 1,034,476 total - Sale
Common Stock
2024-03-08$5.19/sh−25,000$129,685→ 1,040,371 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2023.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $5.00 to $5.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.